Monitoring Drug Safety Information - Recommendations of Foreign Regulatory Authorities

Safety and Risk of Pharmacotherapy
doi 10.30895/2312-7821-2020-8-1-52-54
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SCEEMP

Related search

Monitoring of Information Service Rendering by Government Authorities and Its Consequences

State power and local self-government
2018English

Extended Use or Reuse of N95 Respirators During COVID-19 Pandemic: An Overview of National Regulatory Authorities’ Recommendations

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
2020English

Monitoring Drug Safety: Is the Yellow Card Scheme Struggling?

Prescriber
Pharmacology
2019English

Practical Recommendations for the Use of Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases

Clinical Pharmacology: Advances and Applications
Pharmacology
2017English

Improving the Quality of Healthcare of Russia: Recommendations for State Authorities

Humanities and Social Sciences. Bulletin of the Financial University
2019English

Drug Safety for Children — International Monitoring Data for 50 Years

Safety and Risk of Pharmacotherapy
2019English

Regulatory Gaps in Drug Compounding: Implications for Patient Safety, Innovation, and Fraud

SSRN Electronic Journal
2018English

Implementing Growth Monitoring Recommendations

CMAJ
Medicine
2015English

New Antiarrhythmic Drug for the Treatment of Atrial Fibrillation. Study Data, Clinical Guidelines, Regulatory Agency Recommendations

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy